CVS Lines Up Sandoz’s Adalimumab Biosimilar For US Biosimilars Subsidiary

CVS feels its newly launched, wholly owned US biosimilars subsidiary called Cordavis is a “logical evolution for us and will help ensure sufficient supply of biosimilars in the US and support this market now and in the future.”